Clinical Trial Update: Phase Ia Study of ChAd63/MVA PvDBP [Phase 1]

View source ↗

Summary

A Phase Ia study of the ChAd63/MVA PvDBP vaccine for malaria caused by Plasmodium vivax has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Drugs mentioned

• ChAd63/MVA PvDBP vaccine (ChAd63/MVA PvDBP)

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Plasmodium Vivax | Phase 1 | Status: COMPLETED